Hantavirus cardiopulmonary syndrome is an emerging zoonosis in Argentina, which has low incidence but high death rates. No specific pharmacological therapy is available and symptomatic therapy is the only current alternative. This article presents the pathogenesis of hantavirus cardiopulmonary syndrome through a review of clinical experiences in neighbor South American countries, mainly Chile, and the experience acquired at the Infectious Diseases Hospital Francisco Javier Muñiz, Buenos Aires, Argentina. The role of early corticosteroid therapy is discussed taking into account that there is insufficient evidence favoring its use in the hantavirus cardiopulmonary syndrome.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hantavirus cardiopulmonary
16
cardiopulmonary syndrome
12
corticosteroid therapy
8
[controversies corticosteroid
4
therapy
4
hantavirus
4
therapy hantavirus
4
cardiopulmonary
4
cardiopulmonary syndrome]
4
syndrome] hantavirus
4

Similar Publications

Knowledge, risk perceptions and practices regarding rodents and their associated pathogens: environmental consultants in Chile.

One Health Outlook

December 2024

Departamento de Ciencias Biológicas Animales, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Av. Santa Rosa 11735, Santiago, Chile.

Article Synopsis
  • Rodents are crucial to the ecosystem but also carry diseases that can harm humans, which is particularly concerning for environmental consultants (ECs) in Chile who often work closely with them.
  • A study involving a 32-item questionnaire highlighted that while ECs knew about the hantavirus, there were significant gaps in their understanding of other rodent-borne diseases and the specific rodent species that carry them.
  • Many ECs reported using live traps and directly handling rodents, leading to injuries; although they frequently used personal protective equipment, they often lacked adequate respiratory protection and disposable suits.
View Article and Find Full Text PDF
Article Synopsis
  • - Pathogenic hantaviruses, carried by asymptomatic rodents worldwide, can spill over to humans causing severe diseases, but there are no approved treatments or vaccines available for these infections.
  • - Recent studies are exploring how these rodents can persistently host dangerous viruses without getting sick, focusing on two main ideas: muted immune responses in reservoir cells and the viruses' ability to evade immune detection.
  • - Research showed that while human cells respond robustly to hantavirus infections, rat endothelial cells do not activate antiviral responses when infected with their native hantavirus (SEOV), suggesting that efficient viral replication might help these cells avoid triggering immune defenses.
View Article and Find Full Text PDF
Article Synopsis
  • * A study found that 30% of Rattus norvegicus tested positive for Seoul hantavirus (SEOV), with 12.5% showing coinfection with Leptospira.
  • * Immunohistochemical analyses showed distinct locations for hantavirus and Leptospira in rat kidneys, highlighting the high prevalence of these pathogens and the potential public health risks they pose in the region.
View Article and Find Full Text PDF

New World orthohantaviruses are rodent-borne tri-segmented viruses that cause hantavirus cardiopulmonary syndrome in humans in the Americas. Molecular diagnostics for orthohantaviruses can be improved with more sequence data. Reported here are completed genomes for Lechiguanas, Maciel, and Laguna Negra viruses.

View Article and Find Full Text PDF

Orthohantavirus infections in South America: a systematic review and meta-analysis.

Arch Virol

August 2024

Fundação Ezequiel Dias (FUNED), Diretoria de Pesquisa e Desenvolvimento, Divisão de Ciência e Inovação, 80 Conde Pereira Carneiro Street, Gameleira, Belo Horizonte, MG, CEP: 30.510-010, Brasil.

Article Synopsis
  • Orthohantaviruses are zoonotic pathogens that can cause serious health issues in humans, and this review covers their occurrence in South America from 2010 to 2022.
  • The study analyzed 32 research articles, identifying 1,962 confirmed cases among over 35,500 individuals, resulting in an estimated occurrence rate of 4.4% of orthohantavirus infections.
  • The review also found significant variations in infection rates across different South American countries and highlighted the presence of four genetic variants of the virus in the region.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!